Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · Real-Time Price · USD
3.490
+0.100 (2.95%)
Jul 2, 2025, 4:00 PM - Market closed
Ekso Bionics Holdings Market Cap
Ekso Bionics Holdings has a market cap or net worth of $6.76 million as of July 2, 2025. Its market cap has decreased by -67.04% in one year.
Market Cap
6.76M
Enterprise Value
4.32M
1-Year Change
-67.04%
Ranking
Category
Stock Price
$3.49
Market Cap Chart
Since March 31, 2014, Ekso Bionics Holdings's market cap has decreased from $250.40M to $6.76M, a decrease of -97.30%. That is a compound annual growth rate of -27.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 6.60M | -50.75% |
| Dec 31, 2024 | 13.40M | -62.36% |
| Dec 29, 2023 | 35.60M | 128.21% |
| Dec 30, 2022 | 15.60M | -53.57% |
| Dec 31, 2021 | 33.60M | -34.12% |
| Dec 31, 2020 | 51.00M | 74.06% |
| Dec 31, 2019 | 29.30M | -62.29% |
| Dec 31, 2018 | 77.70M | -39.11% |
| Dec 29, 2017 | 127.60M | 46.50% |
| Dec 30, 2016 | 87.10M | -16.57% |
| Dec 31, 2015 | 104.40M | -2.34% |
| Dec 31, 2014 | 106.90M | -57.31% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.55B |
| Johnson & Johnson | 375.15B |
| AbbVie | 335.60B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 295.85B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 237.07B |
| AstraZeneca | 221.11B |